Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:5
  • preuzimanja u poslednjih 30 dana:3
članak: 2 od 22  
Back povratak na rezultate
Archive of Oncology
2020, vol. 26, br. 2, str. 30-34
jezik rada: engleski
vrsta rada: članak
doi:10.2298/AOO190717010D
Creative Commons License 4.0
Local recurrence after surgery of locally advanced rectal cancer treated with or without preoperative chemoradiotherapy
(naslov ne postoji na srpskom)
aUniverzitet u Novom Sadu, Medicinski fakultet, Institut za onkologiju
bOncology Institute of Vojvodina Sremska Kamenica, Department of Surgical Oncology + University of Novi Sad, Faculty of Medicine

e-adresa: djuric.mladen@onk.ns.ac.rs

Sažetak

(ne postoji na srpskom)
Introduction: The "gold standard" for patients with locally advanced rectal cancer is neoadjuvant chemoradiotherapy followed by surgery. Aim: Evaluation of local recurrence after surgery for locally advanced rectal cancer. Methods and patients: Retrospective study included 189 patients, who were operated at Oncology Institute of Vojvodina from January 1 st 2012 until December 31 st 2017. Patients were divided into two groups. In the first group 73 patients who received chemoradiotherapy were included, while 116 patients without neoadjuvant treatment were in the second group. All patients were diagnosed with locally advanced rectal cancer. The existence of operable metastases in the liver and/or lungs did not exclude patients from the study. Patients who had undergone resection of the rectum by Miles, Hartmann or local tumor excision were excluded from the study. Results: The median follow-up period was 48 months (range 13-84). In total, 23 (12.2%) patients developed local recurrence. In the chemoradiotherapy group, 15.1% (11 of 73 patients) had a local recurrence, as compared with 10.3% (12 of 116 patients) in the group without neoadjuvant treatment. In both groups, there were no correlation between rate of local recurrence with other clinical and pathological parameters such as gender, tumor location, T and N stage, histological differentiation, or lympho-vascular and perineural invasion (p>0.05). We confirmed significant association between circumferential resection margin with local recurrence in patients who were treated by preoperative chemoradiation (p=0.014). Conclusion: This study has not shown reduced risk of local recurrence after neoadjuvant therapy most likely due to small number of patients. Despite our results, neoadjuvant treatment followed by surgery remains the best treatment protocol for patients with locally advanced rectal cancer.

Ključne reči

Rectal cancer; Total mesorectal excision; Recurrence

Reference

Bosset, J., Collette, L., Calais, G., Mineur, L., Maingon, P., Radosevic-Jelic, L., Daban, A., Bardet, E., Beny, A., Ollier, J. (2006) Chemotherapy with Preoperative Radiotherapy in Rectal Cancer. New England Journal of Medicine, 355(11): 1114-1123
Chabowski, M., Nowak, A., Grzegrzolka, J., Piotrowska, A., Janczak, D., Dziegiel, P. (2018) Comparison of Microvessel Density Using Nestin and CD34 in Colorectal Cancer. Anticancer Research, 38(7): 3889-3895
Cienfuegos, J.A., Rotellar, F., Baixauli, J., Beorlegui, C., Sola, J.J., Arbea, L., Pastor, C., Arredondo, J., Hernández-Lizoáin, J.L. (2015) Impact of Perineural and Lymphovascular Invasion on Oncological Outcomes in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Surgery. Annals of Surgical Oncology, 22(3): 916-923
Dayde, D., Tanaka, I., Jain, R., Tai, M., Taguchi, A. (2017) Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer. International Journal of Molecular Sciences, 18(3): 573
Dieguez, A. (2013) Rectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging. Cancer Imaging, 13(2): 277-297
García-Aguilar, J., Hernandez, D.A.E., Sirivongs, P., Lee, S., Madoff, R.D., Rothenberger, D.A. (2003) A Pathologic Complete Response to Preoperative Chemoradiation Is Associated with Lower Local Recurrence and Improved Survival in Rectal Cancer Patients Treated by Mesorectal Excision. Diseases of the Colon & Rectum, 46(3): 298-304
Gérard, J., Conroy, T., Bonnetain, F., Bouché, O., Chapet, O., Closon-Dejardin, M., Untereiner, M., Leduc, B., Francois, É., Maurel, J., Seitz, J., Buecher, B., Mackiewicz, R., Ducreux, M. (2006) Preoperative Radiotherapy with or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203. Journal of Clinical Oncology, 24(28): 4620-4625
Habr-Gama, A., Perez, R.O., Nadalin, W., Sabbaga, J., Ribeiro, U., Sousa, A.H., Campos, F.G., Kiss, D.R.R., Gama-Rodrigues, J. (2004) Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy. Transactions of the ... Meeting of the American Surgical Association, CXXII(&NA;): 309-316
Hav, M., Libbrecht, L., Ferdinande, L., Geboes, K.L., Pattyn, P., Cuvelier, C.A. (2015) Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic Implications. BioMed Research International, 2015: 1-11
Huh, J.W., Kim, Y.J., Kim, H.R. (2010) Ratio of Metastatic to Resected Lymph Nodes as a Prognostic Factor in Node-Positive Colorectal Cancer. Annals of Surgical Oncology, 17(10): 2640-2646
Jin, C., Deng, X., Li, Y., He, W., Yang, X., Liu, J. (2018) Lymph node ratio is an independent prognostic factor for rectal cancer after neoadjuvant therapy: A meta-analysis. Journal of Evidence-Based Medicine, 11(3): 169-175
Kim, C.H., Yeom, S., Lee, S.Y., Kim, H.R., Kim, Y.J., Lee, K.H., Lee, J.H. (2019) Prognostic Impact of Perineural Invasion in Rectal Cancer After Neoadjuvant Chemoradiotherapy. World Journal of Surgery, 43(1): 260-272
Li, Y., Wang, J., Ma, X., Tan, L., Yan, Y., Xue, C., Hui, B., Liu, R., Ma, H., Ren, J. (2016) A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. International Journal of Biological Sciences, 12(8): 1022-1031
Maas, M., Nelemans, P.J., Valentini, V., Das, P., Rödel, C., Kuo, L., Calvo, F.A., García-Aguilar, J., Glynne-Jones, R., Haustermans, K., Mohiuddin, M., Pucciarelli, S., Small, W., Suárez, J. (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncology, 11(9): 835-844
Nikberg, M., Chabok, A., Letocha, H., Kindler, C., Glimelius, B., Smedh, K. (2016) Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry. Acta Oncologica, 55(12): 1418-1424
Park, B.K., Lee, S.J., Hur, B.Y., Kim, M.J., et al. (2018) Feasibility of Selective Lateral Node Dissection Based on Magnetic Resonance Imaging in Rectal Cancer After Preoperative Chemoradiotherapy. Journal of Surgical Research, 232: 227-233
Peng, J., Xu, Y., Guan, Z., Zhu, J., Wang, M., Cai, G., Sheng, W., Cai, S. (2008) Prognostic Significance of the Metastatic Lymph Node Ratio in Node-Positive Rectal Cancer. Annals of Surgical Oncology, 15(11): 3118-3123
Petrović, T., Radovanović, Z., Bokorov, B., Nikolić, I., Knežević-Ušaj, S., Čanković, M. (2010) Analysis of patients with complete histopathological tumour regression after neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Archive of Oncology, vol. 18, br. 1-2, str. 3-7
Petrović, T., Breberina, M., Radovanović, Z., Nikolić, I., Ivković-Kapicl, T., Vukadinović-Miučin, I., Patrnogić, A., Gavrančić, B. (2010) The results of the surgical treatment of rectal cancer. Archive of Oncology, vol. 18, br. 3, str. 51-55
Quirke, P., Steele, R., Monson, J., Grieve, R., Khanna, S., Couture, J., o'Callaghan Chris,, Myint, A.S., Bessell, E., Thompson, L.C., Parmar, M., Stephens, R.J., Sebag-Montefiore, D. (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet, 373(9666): 821-828
Roh, M.S., Colangelo, L.H., O'Connell, M.J., Yothers, G., Deutsch, M., Allegra, C.J., Kahlenberg, M.S., Baez-Diaz, L., Ursiny, C.S., Petrelli, N.J., Wolmark, N. (2009) Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients with Carcinoma of the Rectum: NSABP R-03. Journal of Clinical Oncology, 27(31): 5124-5130
Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C.F., Karstens, N., Liersch, T., Schmidberger, H., Raab, R. (2004) Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. New England Journal of Medicine, 351(17): 1731-1740
van Gijn, W., Marijnen, C.A., Nagtegaal, I.D., Kranenbarg, E.M.M., Putter, H., Wiggers, T., Rutten, H.J., Påhlman, L., Glimelius, B., van de Velde, C.J. (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncology, 12(6): 575-582
Wells, B.J., Stotland, P., Ko, M.A., Al-Sukhni, W., Wunder, J., Ferguson, P., Lipa, J., Last, L., Smith, A.J., Swallow, C.J. (2007) Results of an Aggressive Approach to Resection of Locally Recurrent Rectal Cancer. Annals of Surgical Oncology, 14(2): 390-395
Wheeler, J.M.D., Dodds, E., Warren, B.F., Cunningham, C., George, B.D., Jones, A.C., Mortensen, N. (2004) Preoperative Chemoradiotherapy and Total Mesorectal Excision Surgery for Locally Advanced Rectal Cancer: Correlation with Rectal Cancer Regression Grade. Diseases of the Colon & Rectum, 47(12): 2025-2031
Yun, H.R., Lee, L.J., Park, J.H., Cho, Y.K., Cho, Y.B., Lee, W.Y., Kim, H.C., Chun, H.K., Yun, S.H. (2008) Local recurrence after curative resection in patients with colon and rectal cancers. International Journal of Colorectal Disease, 23(11): 1081-1087